Northern Trust’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $194K | Buy |
69,235
+2,410
| +4% | +$6.7K | ﹤0.01% | 3945 |
|
|
2026
Q1 | $172K | Buy |
66,825
+11,057
| +20% | +$32.7K | ﹤0.01% | 3985 |
|
|
2025
Q4 | $174K | Sell |
55,768
-1,192
| -2% | -$4.88K | ﹤0.01% | 4027 |
|
|
2025
Q3 | $188K | Sell |
56,960
-9,722
| -15% | -$30.8K | ﹤0.01% | 4001 |
|
|
2025
Q2 | $220K | Hold |
66,682
| – | – | ﹤0.01% | 3908 |
|
|
2025
Q1 | $191K | Hold |
66,682
| – | – | ﹤0.01% | 3959 |
|
|
2024
Q4 | $155K | Sell |
66,682
-4,358
| -6% | -$13.5K | ﹤0.01% | 4061 |
|
|
2024
Q3 | $224K | Hold |
71,040
| – | – | ﹤0.01% | 3847 |
|
|
2024
Q2 | $157K | Buy |
71,040
+8,378
| +13% | +$23.8K | ﹤0.01% | 3935 |
|
|
2024
Q1 | $196K | Buy |
62,662
+11,165
| +22% | +$44.5K | ﹤0.01% | 3903 |
|
|
2023
Q4 | $200K | Sell |
51,497
-1,947
| -4% | -$6.57K | ﹤0.01% | 3900 |
|
|
2023
Q3 | $175K | Sell |
53,444
-418
| -0.8% | -$1.46K | ﹤0.01% | 3867 |
|
|
2023
Q2 | $172K | Sell |
53,862
-4,611
| -8% | -$17.8K | ﹤0.01% | 3880 |
|
|
2023
Q1 | $251K | Sell |
58,473
-42
| -0.1% | -$184 | ﹤0.01% | 3750 |
|
|
2022
Q4 | $249K | Hold |
58,515
| – | – | ﹤0.01% | 3763 |
|
|
2022
Q3 | $288K | Buy |
58,515
+1,597
| +3% | +$6.47K | ﹤0.01% | 3696 |
|
|
2022
Q2 | $174K | Hold |
56,918
| – | – | ﹤0.01% | 3982 |
|
|
2022
Q1 | $156K | Sell |
56,918
-3,311
| -5% | -$9.71K | ﹤0.01% | 4212 |
|
|
2021
Q4 | $179K | Sell |
60,229
-1,053
| -2% | -$4.26K | ﹤0.01% | 4234 |
|
|
2021
Q3 | $292K | Hold |
61,282
| – | – | ﹤0.01% | 3996 |
|
|
2021
Q2 | $238K | Buy |
61,282
+12,195
| +25% | +$51.9K | ﹤0.01% | 4080 |
|
|
2021
Q1 | $230K | Sell |
49,087
-204
| -0.4% | -$975 | ﹤0.01% | 4063 |
|
|
2020
Q4 | $151K | Sell |
49,291
-2,721
| -5% | -$6.84K | ﹤0.01% | 4031 |
|
|
2020
Q3 | $127K | Buy |
52,012
+6,291
| +14% | +$16.2K | ﹤0.01% | 3908 |
|
|
2020
Q2 | $140K | Sell |
45,721
-8,001
| -15% | -$16.6K | ﹤0.01% | 3845 |
|
|
2020
Q1 | $86K | Buy |
53,722
+100
| +0.2% | +$293 | ﹤0.01% | 3854 |
|
|
2019
Q4 | $176K | Sell |
53,622
-2,371
| -4% | -$8.7K | ﹤0.01% | 3816 |
|
|
2019
Q3 | $224K | Sell |
55,993
-3,000
| -5% | -$12.6K | ﹤0.01% | 3734 |
|
|
2019
Q2 | $214K | Hold |
58,993
| – | – | ﹤0.01% | 3809 |
|
|
2019
Q1 | $267K | Buy |
58,993
+338
| +0.6% | +$1.61K | ﹤0.01% | 3707 |
|
|
2018
Q4 | $231K | Buy |
58,655
+17,147
| +41% | +$73.7K | ﹤0.01% | 3765 |
|
|
2018
Q3 | $193K | Buy |
41,508
+4,960
| +14% | +$18.7K | ﹤0.01% | 3876 |
|
|
2018
Q2 | $111K | Hold |
36,548
| – | – | ﹤0.01% | 3994 |
|
|
2018
Q1 | $140K | Buy |
36,548
+16,248
| +80% | +$62.5K | ﹤0.01% | 3893 |
|
|
2017
Q4 | $48K | Buy |
20,300
+4,599
| +29% | +$11.9K | ﹤0.01% | 4077 |
|
|
2017
Q3 | $41K | Buy |
+15,701
| New | +$17.3K | ﹤0.01% | 4083 |
|
Other funds holding ANIX
LNWTC
DADC
GCP
Northern Trust's ANIX Position: Q2 2026 in Review
Northern Trust increased its Anixa Biosciences (ANIX) stake by 3.6% in Q2 2026, buying an estimated $6.7K and bringing the position to 69,235 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #3945.
Northern Trust first reported a position in ANIX in Q3 2017 and has held it in 36 quarters since. The position peaked at $292K in Q3 2021. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.
- Northern Trust held 69,235 shares of Anixa Biosciences worth $194K as of Q2 2026.
- Northern Trust bought 2,410 Anixa Biosciences shares in Q2 2026, an estimated $6.7K.
- Anixa Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3945 holding.
- Northern Trust first reported a position in Anixa Biosciences in Q3 2017 and has held it in 36 quarters since.
- Northern Trust's Anixa Biosciences position peaked at $292K in Q3 2021.
- 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.